Thimerosal
Small moleculeexperimental
Clinical trial activity
4 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
1
Phase 4
0
Earliest trial started Jun 1, 2006 (NCT00333398)
Timeline
Indications
Mechanism of action
- Unspecified targetOTHER
Antimicrobial preservative, used in vaccines
Chemistry & pharmacology
- Mol. weight
- 382.83 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL508338 ↗
- ChEMBLCHEMBL223620 ↗
Also known as
- btl-tml-hsv
- ethyl(2-mercaptobenzoato-s)mercury sodium salt
- ethyl(2-mercaptobenzoato-s)mercury sodium salt
- ethylmercurithiosalicylate sodium
- ethylmercurithiosalicylate sodium
- ethylmercurithiosalicylate sodium salt
- ethylmercurithiosalicylic acid sodium salt
- ethylmercurithiosalicylic acid sodium salt
- ethylmercury sodium salt
- ethylmercury sodium salt
- ethylmercutythiosalycilic acid
- mercurothiolate
- mercurothiolate
- mercurothiolate
- mercurothiolate
- merfamin
- merfamin
- merthiolate
- merthiolate
- merthiolate
- merthiolate sodium
- mertorgan
- mertorgan
- merzonin
- merzonin
- [(o-carboxyphenyl)thio]ethylmercury sodium salt
- [(o-carboxyphenyl)thio]ethylmercury sodium salt
- o-(ethylmercurithio)benzoic acid sodium salt
- o-(ethylmercurithio)benzoic acid sodium salt
- sodium ethylmercurithiosalicylate
- sodium ethylmercurithiosalicylate
- sodium ethylmercurithiosalicylate
- sodium merthiolate
- sodium merthiolate
- sodium merthiolate
- thimerosal
- thimerosal
- thimerosal
- thimerosal
- thimerosal
- thimersalate
- thiomerosal
- thiomerosal
- thiomersal
- thiomersal
- thiomersal
- thiomersal
- thiomersal
- thiomersal
- thiomersalate
- thiomersalate
- thiomersalate
- thiomersalate
- thiomersalum
- thiomersalum
- tiomersal
- tiomersal
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04522830 | Phase 2 | Jul 30, 2020 | Allegiance Health, Beech Tree Labs, Inc., Curavit Clinical Research, Norwich Clinical Research Associates Ltd. |
| NCT01902303 | Phase 2 | Jul 1, 2013 | Beech Tree Labs, Inc., Hill Top Research, Norwich Clinical Research Associates Ltd. |
| NCT01308424 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2011 | Beech Tree Labs, Inc., Norwich Clinical Research Associates Ltd. |
| NCT00333398 | Phase 3 | Jun 1, 2006 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Beech Tree Labs, Inc. | For profit | 3 | 3 | 1 | 2011 |
| Norwich Clinical Research Associates Ltd. | For profit | 3 | 0 | 1 | 2011 |
| Allegiance Health | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Curavit Clinical Research | For profit | 1 | 0 | 1 | 2020 |
| Hill Top Research | For profit | 1 | 0 | 1 | 2013 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2006 |
6 organizations
Page 1 / 1